InvestorsHub Logo
Followers 65
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

Re: biopharm post# 294301

Saturday, 04/08/2017 9:21:59 AM

Saturday, April 08, 2017 9:21:59 AM

Post# of 346050

This study established the phosphatidylserine movement as a hallmark of necroptosis.



Thank you bio...this helps me in my thought process immensely.


I want to present the following notion...

DNA histone complex



http://www.peregrineinc.com/pipeline/cotara-oncology.html


I think that Cotara could have a role in this (new to me<necroptosis>) angle for treatment AND diagnostics in addition to PS targeting.

Can Peregrine integrate both targeting platforms for an even more accurate test that may have even better differentiation between apoptosis and necroptosis? Would that even be valuable? I say yes.

I don't recall ever seeing "necroptosis" AND IT IS HHhhhYYYyyuuuugggeeee. IMHO

Is there a diagnostic application for Tumor Necrosis Therapy? DNA Histone Targeting? Dig Deeper?

wook

Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!!
Research.
Always looking deeper. RIP Dr. Thorpe

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News